Podium to Practice: EHA 2025 – Multiple Myeloma: FORTE TRIAL

Podium to Practice: EHA 2025 – Multiple Myeloma: FORTE TRIAL

Podium to Practice: EHA 2025
Explore more from your favourite experts – click their name to access their entire library of content.
Icon Chair Speaker

Chair

Dr. Donna Reece

Icon Chair Speaker

Speakers

Dr. Irwin Sandhu

Dr. Maria Victoria Mateos Manteca

Studies / Trials Discussed

S194 – CARFILZOMIB INDUCTION, CONSOLIDATION, AND MAINTENANCE WITH OR WITHOUT AUTOLOGOUS STEM-CELL TRANSPLANT: LONG-TERM FOLLOW-UP OF THE RANDOMISED, PHASE 2 FORTE TRIAL

Studies/trials discussed:

S194 – CARFILZOMIB INDUCTION, CONSOLIDATION, AND MAINTENANCE WITH OR WITHOUT AUTOLOGOUS STEM-CELL TRANSPLANT: LONG-TERM FOLLOW-UP OF THE RANDOMISED, PHASE 2 FORTE TRIAL
Tagged